logo
Select company
Select metric
0.53%Interest Expense Margin
VS
Market
63
Sector
59
Industry
48
History
18
$ 1.65Close
$ 1.06 - $ 4.46 52-Week Range
Ticker Information

Ticker

MGNX

Company Name

MACROGENICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MACROGENICS INC - Interest Expense Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MGNX - Int. Exp. % Historical data
DateInterest ExpenseInterest Expense MarginRevenues
6/30/2025$ 869K0.53%$ 165.49M
3/31/2025$ 73K0.05%$ 154.05M
12/31/2024$ 1.11M0.74%$ 149.96M
9/30/2024$ 1.14M0.81%$ 141.33M
6/30/2024$ 1.14M2.78%$ 41.02M
3/31/2024$ 1.91M4.4%$ 43.36M
12/31/2023$ 1.43M2.43%$ 58.75M
9/30/2023$ 1.43M1.18%$ 121.13M
6/30/2023$ 1.43M0.94%$ 152.47M
3/31/2023$ 656K0.4%$ 165.34M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MACROGENICS INC's latest trailing twelve months (TTM) Int. Exp. % stands at 0%.
  • Over the past 5 years, MACROGENICS INC's average Int. Exp. % has been 0.71%.
  • The median Int. Exp. % for MACROGENICS INC during this period was 0.02%
  • MACROGENICS INC reached its highest Int. Exp. % over the past 5 years at 4.4%.
  • The lowest Int. Exp. % recorded by MACROGENICS INC in the same timeframe 0%

MACROGENICS INC's Int. Exp. % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Int. Exp. % Benchmarks
CompanyInt. Exp. %
CHRS : COHERUS ONCOLOGY INC 10.6%IGMS : IGM BIOSCIENCES INC 0%ATRA : ATARA BIOTHERAPEUTICS INC 2.22%STRO : SUTRO BIOPHARMA INC 22.6%AGEN : AGENUS INC 81.12%CELU : CELULARITY INC 17.82%CSBR : CHAMPIONS ONCOLOGY INC 0%IVVD : INVIVYD INC 0%PLX : PROTALIX BIOTHERAPEUTICS INC 1.77%BDTX : BLACK DIAMOND THERAPEUTICS INC 0%

Definition of Interest Expense Margin

[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
Int. Exp. / Revenues
(=) Int. Exp. %
Int. Exp. % for MACROGENICS INC is calculated as follows: Int. Exp. [ $ 0 ] / Revenues [ $ 77.38M ]
(=) Int. Exp. % [ 0% ]

MGNX - Interest Expense Margin, Last 5 years

0%

Minimum

Sep 30, 2020

4.4%

Maximum

Mar 31, 2024

0.71%

Average

0.02%

Median

Int. Exp. % Benchmark Analysis

The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.63% with a standard deviation of 2.2%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
filtered constituents3.15K
min-4.94%
max8.49%
average1.63%
median0.79%
std2.2%